Anthony Fauci to retire after four decades of scientific leadership

23 August 2022

The face of the USA’s response to the coronavirus pandemic, Anthony Fauci, has announced he will step down from his role as Director of the National Institute of Allergy and Infectious Diseases (NIAID).

Dr Fauci, who said he plans to focus on personal projects outside of government following his retirement, has led the NIAID for 38 years and advised seven US presidents as Chief Medical Advisor, a role he will also step down from.

During his time, Dr Fauci has advised on emerging infectious diseases, including HIV/AIDS, as well as anthrax attacks, Ebola and the Zika virus.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK